GENEVA, Sept. 21 -- ODIMMA THERAPEUTICS (8 ALLEE GASPARD MONGE67000 STRASBOURG) filed a patent application (PCT/EP2025/056661) for "NON-VIRAL VECTOR FOR ENHANCED TRANSCRIPTION" on Mar 11, 2025. With publication no. WO/2025/190971, the details related to the patent application was published on Sep 18, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): MARSCHALL, Pierr (1 RUE HENRI LEBERT68000 COLMAR)
Abstract:
The invention relates to a non-viral vector comprising a gene of interest functionally linked to a eukaryotic promoter and to a promoter of a cytoplasmic replication virus. The inventio...